These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30484950)

  • 1. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.
    Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
    Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
    Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway.
    Wu N; Han Y; Liu H; Jiang M; Chu Y; Cao J; Lin J; Liu Y; Xu B; Xie X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1491-1497. PubMed ID: 30029874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway.
    Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD
    Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
    Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
    J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
    Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels.
    Wang X; Lin Y; Liu S; Zhu Y; Lu K; Broering R; Lu M
    FASEB J; 2020 Nov; 34(11):14473-14489. PubMed ID: 32892442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
    Harosh-Davidovich SB; Khalaila I
    Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
    Jiang M; Xu B; Li X; Shang Y; Chu Y; Wang W; Chen D; Wu N; Hu S; Zhang S; Li M; Wu K; Yang X; Liang J; Nie Y; Fan D
    Oncogene; 2019 Jan; 38(3):301-316. PubMed ID: 30093632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer.
    Very N; Hardivillé S; Decourcelle A; Thévenet J; Djouina M; Page A; Vergoten G; Schulz C; Kerr-Conte J; Lefebvre T; Dehennaut V; El Yazidi-Belkoura I
    Oncogene; 2022 Jan; 41(5):745-756. PubMed ID: 34845374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway.
    Ding Y; Lv C; Zhou Y; Zhang H; Zhao L; Xu Y; Fan X
    Exp Cell Res; 2021 Aug; 405(1):112666. PubMed ID: 34052237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA binding motif protein 3 (RBM3) promotes protein kinase B (AKT) activation to enhance glucose metabolism and reduce apoptosis in skeletal muscle of mice under acute cold exposure.
    Liu Y; Shi H; Hu Y; Yao R; Liu P; Yang Y; Li S
    Cell Stress Chaperones; 2022 Nov; 27(6):603-618. PubMed ID: 36149580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.